glp-1 shortage canada news today New study ties weight-loss drugs Wegovy, Ozempic to serious gastrointestinal conditions New GLP-1 cardiovascular study raises

But if you're hoping it'll be the thing that finally makes weight loss easy

But Noom is the latest in a string of digital health companies to offer compounded versions of the medications as a cheaper alternative for consumers while demand for weight loss and diabetes drugs spikes

Here's what we believe matters

Novo Nordisks Response to the Lawsuits Novo Nordisks Response to the Lawsuits In the face of mounting legal challenges regarding Ozempic, Novo Nordisk has adopted a multi-faceted approach to address the concerns and defend its product: Official Statements and Public Defense: Novo Nordisk has consistently maintained that patient safety is its highest priority

doi: 10.1210/jc.2003-032001

The recently launched, government-run website is aims to help Americans access discounted prescription drugs by connecting users with manufacturers direct-to-consumer purchasing pages and pharmacy coupon offers.